Duloxetine for the Treatment of Generalized Anxiety Disorder

Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China

This is a 15 week study comparing how well duloxetine and placebo treatments improve generalized anxiety disorder

Inclusion Criteria:

• Psychiatric Diagnosis of generalized anxiety disorder (GAD)
• Outpatients
• Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis for GAD
• Clinical Global Impression (CGI) of Severity Score of at least moderate
• Sheehan Disability Scale (SDS) Global Functioning Impairment Score >= 12

Exclusion Criteria:

• Pregnancy or breast feeding
• Serious medical illness
• Other primary psychiatric diagnoses, such as major depressive disorder or substance abuse disorder within the past 6 months
• panic disorder, post-traumatic stress disorder (PTSD), or eating disorder in the last year
• lifetime history of bipolar or psychosis
• Any unstable serious medical condition for which duloxetine would not be allowed
• Any use of medications that are not allowed